Skip to main content
OpenTrials
Completed

NCT Number: NCT01649349

The Feasibility Study of Dual-Section Nasogastric Tube

The purpose of this studyis to assess the feasibility and safety of novel designed two-piece nasogastric tube.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • dysphagia
  • mouth neoplasms
  • stroke
  • already use conventional nasogastric tube for at least 2 weeks

Exclusion criteria

  • unconsciousness patient
  • unstable medical condition with needs of closely medical care
  • unable to fill in inform consent
  • the fixed length was less than 50 or more than 60 centimeter when using conventional nasogastric tube

Treatment and study plan

two-piece nasogastric tube

Device

one week period

Primary outcomes

  1. Number of Participants with Adverse Events

    Time frame: participants will be followed for the duration of hospital stay, an expected average of 1 weeks

    monitor the adverse events like pressure sore, numbers of self-extubation, dislocation of tube, or other unpredictable events.

Secondary outcomes

  1. satisfaction of Dual-Section Nasogastric Tube

    Time frame: participants will be followed for the duration of hospital stay, an expected average of 1 weeks

    using Likert scale for overall satisfaction

Sponsors and collaborators

Lead sponsor

Changhua Christian Hospital

Other

Registry information

Official study title

The Feasibility Study of Dual-Section Nasogastric Tube in Dysphagia Patients

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Jul 25, 2012
Registry last updated
Jul 25, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.